NuPulse Capital
Physician-Led Cardiovascular Investment

De-risk cardiovascular innovation through clinical alignment before capital.

NuPulse Capital is a physician-led investment platform that deploys capital into early-stage cardiovascular companies. We partner with clinical founders and experienced teams to establish strategic buyer alignment and clinical proof points, reducing risk and accelerating value creation for all stakeholders.

For Investors For Founders
One Platform

Value for everyone at the table.

Cardiovascular outcomes are decided where clinicians, founders, capital, and acquirers meet. NuPulse sits at that intersection.

For Limited Partners

Access to de-risked, physician-validated cardiovascular deals positioned for strategic acquisition. Deploy capital through SPVs (per-deal) or upcoming fund with institutional-grade governance, compliance infrastructure, and direct access to the cardiologists who validate technology and drive adoption.

Explore →
 For Founders

More than capital. Clinical expertise that positions your technology in clinical workflows. A playbook for exit positioning that increases enterprise value and reduces path-to-exit friction.

Explore →
 For Physicians

Shape the technologies that will define your practice. Clinical insights drive innovation. Equity participation aligns you with value creation. Your legacy compounds through the companies you helped validate and the careers you influenced.

Explore →
 For Strategic Partners

An external cardiovascular innovation radar. We surface physician-validated, commercialization-ready companies early — with the clinical evidence and KOL conviction the major strategics actually use to act.

Explore →
Our Competitive Moat

The Translation Layer.

Most healthcare innovation fails because innovators speak one language: clinical, technical, or commercial. We speak all three.

Clinical Credibility

Hundreds of practicing cardiologists and electrophysiologists who validate technologies, identify workflow fit, and advise on adoption friction. Clinical due diligence embedded before institutional capital.

Technical Capability

MedTech device expertise. Regulatory and FDA strategy. Production-grade systems thinking that translates physician insight into scalable products.

Commercial Alignment

A large network of your end-users. Embedded relationships with major cardiovascular strategics. Exit positioning designed into company formation, not discovered during diligence.

This translation layer is a competitive advantage. Few teams operate across all three domains simultaneously.

Capital Deployment Model

Two paths to participate.

The dual-path model addresses two distinct LP profiles: those who want control over individual investments, and those who trust the team to deploy capital across a portfolio thesis.

Current

SPV Syndication

Deploy capital per deal. Lower minimums for LP participation. Physicians choose which investments align with their expertise and network. Institutional governance. Transparent terms.

Forthcoming

Fund Launch

A formal fund vehicle will allow LPs to commit capital across a thesis-driven portfolio without per-deal decisions. Physicians retain the ability to participate on a deal-by-deal basis if desired.

Get in touch →
Proof Points

Recent engagement.

We have deployed capital into and advised cardiovascular technology companies. In both cases, our clinical due diligence, strategic guidance, and buyer alignment accelerated the path to institutional validation and strategic positioning.

The Team

A multidisciplinary platform, built by design.

Each founder owns a distinct pillar of building and commercializing a cardiovascular company — so the capabilities compound rather than overlap.

Led by Founder Dr. Jose Osorio — clinical innovation, company formation, and strategic relationships — alongside:

Eyal Alfi
Eyal Alfi
Capital Strategy, Governance & Investment Architecture

Investment leader in banking, credit, and multi-party investment vehicles; founder of New Gables Capital.

Ian Concannon
Ian Concannon
Platform Operations & Execution

Entrepreneur and operator running the systems and execution layer behind NuPulse. Former U.S. Army Ranger and Green Beret officer.

Dr. Saumil Oza
Dr. Saumil Oza
Clinical Validation & Physician Network

Practicing electrophysiologist, KOL, and board member across major cardiovascular organizations.

Get in Touch

Tell us where your interest lies.

SPV (per-deal) or the forthcoming fund — share a few details and we will follow up. For informational purposes only; participation is limited to accredited investors.

Miami, Florida · ian@nupulsecapital.com